---
figid: PMC4494900__oncotarget-06-11725-g003
figtitle: Emerging role of CaMKII in cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4494900
filename: oncotarget-06-11725-g003.jpg
figlink: /pmc/articles/PMC4494900/figure/F3/
number: F3
caption: CaMKII activates cyclin-dependent kinase inhibitor 1B (p27Kip1) via the mitogen-activated/extracellular
  regulated kinase (MEK)/extracellular signal-regulated kinase (Erk) pathway. Activated
  p27kip1 will then inhibit cyclin-dependent kinase 4 (Cdk4)/CyclinD1 complexes, and
  therefore retinoblastoma (Rb) phosphorylation and E2F activation, induce cell cycle
  progression. CaMKII phosphorylates T-lymphoma and metastasis gene 1 (Tiam1) and
  then increases the activation of ras-related C3 botulinum toxin substrate 1(Rac1).
  The activation of Rac1 inhibits the expression of p21CIP/KIP. This leads to a cell
  cycle progression. CaMKII increases the phosphorylation of cell division cycle 25c
  (cdc25c) and actives p34cdc2/Cyclin B, causes the cell cycle progression. CaMKII
  suppresses cell cycle progression by stabilization of p53 via CaMKII-dependent phosphorylation
  of RING-H2 type E3 ligase (Pirh2).
papertitle: The emerging role of CaMKII in cancer.
reftext: Yan-yang Wang, et al. Oncotarget. 2015 May 20;6(14):11725-11734.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9413885
figid_alias: PMC4494900__F3
figtype: Figure
redirect_from: /figures/PMC4494900__F3
ndex: 67a06790-df04-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4494900__oncotarget-06-11725-g003.html
  '@type': Dataset
  description: CaMKII activates cyclin-dependent kinase inhibitor 1B (p27Kip1) via
    the mitogen-activated/extracellular regulated kinase (MEK)/extracellular signal-regulated
    kinase (Erk) pathway. Activated p27kip1 will then inhibit cyclin-dependent kinase
    4 (Cdk4)/CyclinD1 complexes, and therefore retinoblastoma (Rb) phosphorylation
    and E2F activation, induce cell cycle progression. CaMKII phosphorylates T-lymphoma
    and metastasis gene 1 (Tiam1) and then increases the activation of ras-related
    C3 botulinum toxin substrate 1(Rac1). The activation of Rac1 inhibits the expression
    of p21CIP/KIP. This leads to a cell cycle progression. CaMKII increases the phosphorylation
    of cell division cycle 25c (cdc25c) and actives p34cdc2/Cyclin B, causes the cell
    cycle progression. CaMKII suppresses cell cycle progression by stabilization of
    p53 via CaMKII-dependent phosphorylation of RING-H2 type E3 ligase (Pirh2).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CaMKII
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - p53
  - betaTub60D
  - hth
  - stg
  - Cdk4
  - rb
  - ebi
  - E2f2
  - E2f1
  - CycB
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - CycE
  - cyc
  - CAMK2G
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - TP53
  - TP63
  - TP73
  - TIAM1
  - CDC25C
  - RCHY1
  - CDK4
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - CCNB1
  - CCNB2
  - CCNB3
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
---
